Diagnostic tools for bacterial infections in travellers: Current and future options.


Journal

Travel medicine and infectious disease
ISSN: 1873-0442
Titre abrégé: Travel Med Infect Dis
Pays: Netherlands
ID NLM: 101230758

Informations de publication

Date de publication:
Historique:
received: 03 04 2019
revised: 30 04 2020
accepted: 19 08 2020
pubmed: 26 8 2020
medline: 21 8 2021
entrez: 26 8 2020
Statut: ppublish

Résumé

International travel has increased dramatically over the past 50 years, and travel destinations have diversified. Although physicians are more familiar with the panel of aetiological agents responsible for illnesses of returning travellers, thanks to regular epidemiological studies, the spectrum of pathogens potentially encountered in various travel destinations is nevertheless increasing. In addition, the wide array of approaches currently available and addressed in this paper could render the procedures for microbiological analyses increasingly complex. As the time to result is crucial to adequately manage patients, modern approaches have been developed to shorten diagnosis delays. The syndromic approach, which consists of simultaneously testing a wide panel of microorganisms, substantially increases the diagnostic yield with significant time savings, particularly when coupled with point-of-care laboratories. The tools commonly used for this purpose are immunochromatographic tests, mainly targeting bacterial antigens, and multiplex real-time PCR. The emergence of next-generation sequencing technologies, which enable random amplification of genetic material of any microbe present in a clinical specimen, provides further exciting perspectives in the diagnosis of infectious diseases.

Identifiants

pubmed: 32841728
pii: S1477-8939(20)30352-5
doi: 10.1016/j.tmaid.2020.101856
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

101856

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Auteurs

Sophie Alexandra Baron (SA)

Aix Marseille Université, IRD, Assistance Publique Hôpitaux de Marseille (APHM), Microbes, Evolution, Phylogeny and Infection (MEPHI), Marseille, France; IHU Méditerranée Infection, Marseille, France.

Carole Eldin (C)

IHU Méditerranée Infection, Marseille, France; Aix Marseille Univ, IRD, AP-HM, SSA, Vecteurs, Infections Tropicales et Méditerranéennes (VITROME), IHU-Méditerranée Infection, Marseille, France.

Frédérique Gouriet (F)

Aix Marseille Université, IRD, Assistance Publique Hôpitaux de Marseille (APHM), Microbes, Evolution, Phylogeny and Infection (MEPHI), Marseille, France; IHU Méditerranée Infection, Marseille, France.

Grégory Dubourg (G)

Aix Marseille Université, IRD, Assistance Publique Hôpitaux de Marseille (APHM), Microbes, Evolution, Phylogeny and Infection (MEPHI), Marseille, France; IHU Méditerranée Infection, Marseille, France. Electronic address: gregory.dubourg@univ-amu.fr.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH